Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 4, June

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast open access plus

Volume:8   Issue: 4
Pp: 243-252
Kazumori Arai, Sachiko Takano, Takumi Teratani, Yasuhiro Ito, Toshihiro Yamada and Ryushi Nozawa
DOI: 10.2174/156800908784533445
Published on: 01 March, 2012

Cancer Neovascularization and Proinflammatory Microenvironments

Volume:8   Issue: 4
Pp: 253-265
Mitsuko Furuya and Yoshikazu Yonemitsu
DOI: 10.2174/156800908784533481
Published on: 01 March, 2012

Targeting Cancer and Neuropathy with Histone Deacetylase Inhibitors:Two Birds with One Stone?

Volume:8   Issue: 4
Pp: 266-274
V. Rodriguez-Menendez, L. Tremolizzo and G. Cavaletti
DOI: 10.2174/156800908784533508
Published on: 01 March, 2012

The Inhibitor of Growth (ING) Gene Family: Potential Role in Cancer Therapy

Volume:8   Issue: 4
Pp: 275-284
Mehmet Gunduz, Esra Gunduz, Rosario S. Rivera and Hitoshi Nagatsuka
DOI: 10.2174/156800908784533454
Published on: 01 March, 2012

Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy

Volume:8   Issue: 4
Pp: 285-298
Maurizio Bossola, Fabio Pacelli, Antonio Tortorelli, Fausto Rosa and Giovan Battista Doglietto
DOI: 10.2174/156800908784533463
Published on: 01 March, 2012

Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics

Volume:8   Issue: 4
Pp: 299-340
Konstantin V. Balakin, Yan A. Ivanenkov, Sergey E. Tkachenko, Alex S. Kiselyov and Alexandre V. Ivachtchenko
DOI: 10.2174/156800908784533490
Published on: 01 March, 2012

Erratum

Volume:8   Issue: 4
Pp: 341-341

DOI: 10.2174/156800908784533472
Published on: 01 March, 2012